vitiligo clinical trials

Advancing Vitiligo Treatment: Insights on Current and Emerging Therapies by Dr. Rebecca Vasquez
vitiligo patientAt the Skin of Color Update 2024, we had the honor to learn from Dr. Rebecca Vasquez, Associate Professor at UT Southwestern Medical Center, regarding the evolving field of vitiligo management. Vitiligo affects between 0.5% to 2% of the global population, with no racial or gender preference, yet it carries a significant psychological burden for affected individuals.1 Dr. Vasquez emphasized that vi …
vitiligo patient
Latest Advances in the Pathogenesis of Vitiligo | Expert Insights from Dr. John Harris
vitiligoUnderstanding the pathogenesis of vitiligo can help determine new treatment targets. Dr. John Harris, professor and chair of the dermatology department at UMass Chan Medical School, shared the latest advances in understanding what causes vitiligo in an interview with Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium. Watch as Dr. Harris explains the role of the immune …
vitiligo